A single cell can be caught to accurately detect cancer. The technology and products of Dr. Yaguang Deng, the chairman of Three Gorges Medical Inspection, have achieved "early screening" of tumors. Dr. yaguang Deng 's team focuses on the precise detection of cells and molecules, from the medical detection of cells and molecules (such as tumor detection) to food safety detection, and water quality safety detection (seawater and fresh water), three aspects of systemizing for market applications. In terms of early tumor screening, it is the world's leading level, which has been highlighted by Nature, Science and other world's top media.
Dr. Yaguang Deng studied under the American Academy of Sciences, Nobel Prize winners and other well-known biologists and medical scientists. He is a Ph.D. from Tokyo Ocean University, a postdoctoral fellow in the Department of Pathology, University of Florida School of Medicine, and a senior scientist at Stanford University. In the field of tumor research, the single-cell gene mutation analysis technology invented by Yaguang Deng is regarded by his peers as the world's advanced level. In 2007, he presided over and launched the "Circulating Tumor Cell Enrichment and Detection Kit" and "ARIOL Rare Cell Detection Pathology Automation Intelligent System Platform" for the first time in 2007.
On July 23, Dr. Yaguang Deng 's team came to Qingdao Oceantec valley at the invitation of Qingdao Innovation Institute. Under the leadership of the Institute, the team was able to connect with the government, meet with investors and communicate with enterprises, which strengthened the confidence of Dr. Deng Yaguang's team in landing in Qingdao Oceantec valley.
Itinerary 1: Connect with the government
Qingdao Oceantec valley Administration Bureau——On the 23rd, Yanheng Xiao, Director of Qingdao Oceantec valley Administration Bureau and Deputy Secretary of the Party Committee, met with Yaguang Deng, Chairman of Three Gorges Medical Testing, and Yang Ma, Operations Director of Qingdao Innovation Institute. Both parties discussed talent introduction and project implementation. Conducted in-depth exchanges. Relevant persons in charge of the Party and Mass Work Department and the Science and Technology Innovation Department of Qingdao Oceantec valley Administration also participated in the meeting.
Yanheng Xiao welcomed the guests and expressed his gratitude to Stanford for introducing high-quality projects to Blue Valley for investment. He said that Blue Valley's marine scientific and technological innovation resources have a significant agglomeration effect, with a large number of national-brand scientific research institutions, colleges and universities, and marine scientific research. Activities are vigorously carried out, and the innovation and entrepreneurship ecology is diversified. Biomedicine has always been an industry that Blue Valley attaches great importance to. It is hoped that both parties will further strengthen communication and docking, plan a strategic layout in Blue Valley, promote deep-level practical cooperation between the two parties, and help the development of Blue Valley's big health industry. Blue Valley will create an optimal government service environment to promote better and faster development of the enterprise. Yaguang Deng said that Blue Valley has a solid industrial foundation, a good investment environment and a strong entrepreneurial atmosphere, and will come up with feasible plans as soon as possible to speed up the implementation of the project in Blue Valley.
Itinerary 2: Meeting with investment
Orient Securities Capital Investment Co., Ltd.--On the same day, in the conference room of Qingdao Innovation Institute, the team of Dr. Yaguang Deng had an in-depth exchange with Shitao Jiang, managing director of Orient Securities Capital Investment Co., Ltd. Orient Securities Capital Investment Co., Ltd., as a professional capital operation platform under Orient Securities, relies on internal and external resources to carry out professional financial services including equity investment, debt investment, mergers and acquisitions and restructuring globally. The project of Dr. Yaguang Deng’s team is not only world-leading in technology, but also market-oriented, closely following market demand, and received high praise from Topix Capital. The two parties will further communicate and deepen cooperation. At the same time, Qingdao Innovation Institute will also use its own resource channel advantages to help Dr. Yaguang Deng connect investment and financing, promote the linkage of production and investment, and promote the development of the project.
Itinerary 3: Corporate Communication
Qingdao Haijian Group Co., Ltd.-- In the afternoon of the same day, Dr. Yaguang Deng and his entourage visited Qingdao Haijian Group under the leadership of the Research Institute and Blue Valley Management Bureau. Under the leadership of Xiaoli Hong, Director of Strategic Development Department of Qingdao Haijian Group Co., Ltd. and others, they visited the laboratory of Haijian Group. Discussion on biomedical testing and inspection started. Qingdao Haijian Group Co., Ltd. is a wholly state-owned enterprise affiliated to Qingdao City with a registered capital of 1.12 billion yuan. Its main function is to develop the inspection and testing industry and promote the coordinated development of the inspection and testing industry chain. Dr. Yaguang Deng highly praised Haijian Group's cutting-edge technology strength and future development potential, and expressed the hope that it can deepen cooperation in biomedical testing and inspection, and contribute its own value and strength to the development of Haijian Group.
Qingdao Huasaiboman Medical Cell Biology Co., Ltd.-- On the morning of the 24th, Dr. Yaguang Deng’s team led by the Institute and the Blue Valley Management Bureau came to Qingdao Huasaiboman Medical Cell Biology Co., Ltd., Huasaiboman takes the development of cell drugs and the clinical transformation of cell therapy technology as the core, and carries out A bio-tech company that stores and transforms functional cells. The team of Dr. Yaguang Deng has been focusing on precise detection of cells and molecules, especially in medical detection. The two parties will jointly explore and deepen cooperation from the perspective of cell medicine.
The agglomeration effect of Blue Valley's marine scientific and technological innovation resources is prominent, with a large number of national-name scientific research institutions and colleges and universities, marine scientific research activities are vigorously carried out, and the innovation and entrepreneurship ecology is diversified. After the full schedule, Dr. Yaguang Deng 's confidence in landing in Blue Valley has been strengthened. At the same time, he hopes to establish an academician workstation and a Nobel Prize expert workstation.